| |
|
|
|
Proteostasis Ther
|
|
2.14 +0.06 (+2.88%) |
10/17/2017 4:00pm |
|
Open: |
2.09 |
Pre close: |
2.08 |
Target:
|
2.71
|
|
High: |
2.18 |
Low: |
2.06 |
Resistance:
|
2.32
2.71
|
|
Volume: |
66,752 |
Market Cap: |
53.72M |
Support:
|
2.00
1.80
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.13
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
2.08 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
3.03  |
Stochastic Oscillator |
%K(14,3):
|
38.11 |
|
MA(250): |
7.53 |
%D(3): |
44.56 |
|
Average Volume(K) |
3-Month: |
11069
|
52-Week |
High:
|
16.67 |
|
10-Days: |
4491 |
Low: |
1.71 |
|
RSI |
RSI(14):
|
51.39 |
Change(%): |
-82.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.190 |
Return on Equity (ttm) |
-127.8 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-2.750 |
Return on Assets (ttm) |
-61.7 |
Shares Float (M) |
12.63 |
|
EPS Est. Next Year |
-2.450 |
PEG Ratio |
0.00 |
% Held by Insiders |
20.42 |
|
EPS Est. Next Quarter |
-0.750 |
Qtrly Rev. Growth |
-21.0 |
% Held by Institutions |
74.37 |
|
Forward EPS |
-2.442 |
Gross Profit (p.s.) |
0.334 |
Shares Short (K) |
43 |
|
Book Value (p.s.) |
2.040 |
EBITDA (p.s.) |
-2.090 |
P/E |
-0.98 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.05 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-54.41 |
P/S |
162769712.00 |
|
Operating Margin |
-664.11 |
Levered Free Cash Flow
(M) |
-32.84 |
P/CF |
-0.00 |
|
|
|
|
|
|
|
